Experiments on animal model expressing SIRPα variants with the differential binding capacity to human CD47 exhibited that macrophage-regulated phagocytosis and AML-LSC clearance was hinged on the absence of the SIRPα pathway. The gene discussed is SIRPA; the disease is acute myeloid leukemia.